Regenerative Engineering and Translational Medicine

Scope & Guideline

Innovating Biomaterials for Tomorrow's Therapies

Introduction

Welcome to your portal for understanding Regenerative Engineering and Translational Medicine, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2364-4133
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 2015 to 2024
AbbreviationREGEN ENG TRANSL MED / Regen. Eng. Transl. Med.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The journal 'Regenerative Engineering and Translational Medicine' aims to advance the field of regenerative medicine through the publication of high-quality research that explores innovative methodologies and applications of regenerative engineering. The journal primarily focuses on the intersection of biological sciences and engineering, emphasizing the development of novel materials and techniques to enhance tissue regeneration and repair.
  1. Tissue Engineering and Regenerative Medicine:
    The journal covers a wide range of topics related to tissue engineering, including the design and application of scaffolds, biomaterials, and cell therapies to promote regeneration in various tissues and organs.
  2. Stem Cell Research and Applications:
    A significant portion of the research published focuses on the utilization of stem cells, including mesenchymal stem cells, in regenerative therapies, exploring their differentiation potential and therapeutic applications.
  3. Biomaterials Development:
    The journal emphasizes the development of new biomaterials, including hydrogels, nanocomposites, and decellularized matrices, tailored for specific applications in regenerative medicine and tissue engineering.
  4. Advanced Manufacturing Techniques:
    Research on additive manufacturing and bioprinting techniques for creating complex tissue structures is a key area of focus, contributing to the innovative approaches in regenerative engineering.
  5. Translational Medicine:
    The journal aims to bridge the gap between laboratory research and clinical applications, highlighting studies that demonstrate the efficacy of regenerative therapies in clinical settings.
The journal has identified several emerging themes that reflect the current trends in regenerative engineering and translational medicine. These themes are indicative of the evolving landscape of research priorities and technological advancements.
  1. 3D Bioprinting and Scaffold Fabrication:
    There is a growing emphasis on 3D bioprinting technologies and scaffold fabrication techniques, which are crucial for creating complex tissue structures and enhancing the regenerative capabilities of engineered tissues.
  2. Nanotechnology in Regenerative Medicine:
    The integration of nanotechnology into regenerative medicine is gaining traction, with studies focusing on nanomaterials for drug delivery, enhanced healing, and tissue regeneration.
  3. Extracellular Vesicles and Secretome Studies:
    Research exploring the therapeutic potential of extracellular vesicles and the secretome of stem cells is on the rise, highlighting their role in mediating regenerative effects and cell communication.
  4. Smart Biomaterials and Responsive Systems:
    The development of smart biomaterials that respond to environmental stimuli (e.g., pH, temperature) for controlled drug delivery and tissue regeneration is increasingly being explored.
  5. Applications in Neurological Disorders:
    There is growing interest in the application of regenerative engineering principles to neurological disorders, including the use of stem cells and biomaterials for nerve regeneration and repair.

Declining or Waning

While the journal continues to thrive in various areas, some themes have shown a decline in prominence over recent years. This waning interest may reflect shifts in research priorities or the saturation of certain topics within the field.
  1. Traditional Biomaterials without Novel Modifications:
    There seems to be a decreasing focus on traditional biomaterials that lack innovative modifications or applications, as the field increasingly prioritizes advanced materials with enhanced functionalities.
  2. Basic Stem Cell Biology:
    Research primarily focused on the basic biology of stem cells, without direct applications or translational aspects, appears to be less prevalent as the journal shifts towards more applied research.
  3. Non-Engineering Approaches to Regeneration:
    Studies that do not integrate engineering principles or innovative technologies into regenerative medicine are becoming less common, indicating a preference for interdisciplinary research that combines engineering with biological sciences.

Similar Journals

Organogenesis

Advancing the Frontiers of Developmental Biology.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

Journal of Biological Engineering

Elevating Interdisciplinary Collaboration in Biological Sciences
Publisher: BMCISSN: 1754-1611Frequency: 1 issue/year

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Tissue Engineering Part C-Methods

Transforming Ideas into Practices in Biomedical Engineering
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3384Frequency: 12 issues/year

Tissue Engineering Part C: Methods is a prestigious academic journal published by MARY ANN LIEBERT, INC, specializing in the dynamic and rapidly evolving fields of bioengineering and biomedical engineering. With an ISSN of 1937-3384 and E-ISSN 1937-3392, this journal provides a platform for the dissemination of cutting-edge research from 2008 to 2024, showcasing methodologies that advance the science of tissue engineering. Ranked in the second and third quartiles across several categories in 2023, including a notable Q2 in Biomedical Engineering, the journal is recognized for its contributions to the interface of biology and engineering. Additionally, it holds commendable Scopus ranks that highlight its influence and reach within the scientific community. Although it does not offer open access, the journal remains vital for researchers, professionals, and students seeking insightful articles that bridge the gap between theoretical research and practical application in tissues and regenerative medicine. With its rigorous peer-review process and commitment to quality, Tissue Engineering Part C: Methods continues to be an essential resource for those at the forefront of tissue engineering innovations.

ARTIFICIAL ORGANS

Transforming Healthcare Through Artificial Organ Research.
Publisher: WILEYISSN: 0160-564XFrequency: 12 issues/year

ARTIFICIAL ORGANS is a leading academic journal published by Wiley, focusing on the interdisciplinary fields of bioengineering, biomaterials, and biomedical engineering. Established in 1977 and continuing through 2024, this journal plays a pivotal role in advancing research related to artificial organs and their impact on healthcare innovations. With an impressive impact factor and notable Q2 rankings across multiple categories, including Medicine and Biomedical Engineering, ARTIFICIAL ORGANS caters to a global audience of researchers, professionals, and students devoted to the latest developments in organ replacement and regenerative medicine. Although not an open-access journal, it maintains a rich repository of essential research articles, reviews, and case studies that collectively enhance the scientific community's understanding of artificial organ technologies. By publishing high-quality, peer-reviewed content, ARTIFICIAL ORGANS remains a vital source for emerging knowledge and collaborations in the exciting field of artificial organ research.

Stem Cells Translational Medicine

Leading the Charge in Stem Cell Advancements
Publisher: OXFORD UNIV PRESSISSN: 2157-6564Frequency: 12 issues/year

Stem Cells Translational Medicine, published by Oxford University Press, is a leading open-access journal that has been at the forefront of stem cell research since its launch in 2012. With an impressive impact across various categories, it occupies Q2 in Cell Biology and is highly recognized in Q1 for both Developmental Biology and Miscellaneous Medicine in 2023. Its strong Scopus rankings highlight its significance in the fields of Biochemistry, Genetics, and Molecular Biology, achieving an outstanding percentile ranking of 93rd in Developmental Biology. The journal provides a pivotal platform for researchers, professionals, and students to publish and access cutting-edge findings that contribute to the understanding and application of stem cell technology. With a commitment to disseminating high-quality scientific knowledge, Stem Cells Translational Medicine plays a vital role in advancing research and innovation within the rapidly evolving landscape of regenerative medicine.

Stem Cell Research & Therapy

Advancing the Frontiers of Regenerative Medicine
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

American Journal of Stem Cells

Unveiling the potential of stem cells for next-generation therapies.
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-4150Frequency: 1 issue/year

American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.

Stem Cells International

Unlocking the Potential of Regenerative Medicine
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Regenerative Therapy

Pioneering research in regenerative therapy for a healthier tomorrow.
Publisher: ELSEVIERISSN: 2352-3204Frequency:

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.

Biomaterials Research

Pioneering breakthroughs in materials for medicine.
Publisher: AMER ASSOC ADVANCEMENT SCIENCEISSN: 1226-4601Frequency: 1 issue/year

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.